CRISPR Therapeutics Reports Mixed Cancer Trial Results

CRISPR Therapeutics Reports Mixed Cancer Trial Results

The death of a clinical trial participant overshadowed clear signs of efficacy for the company's off-the-shelf cellular therapy for non-Hodgkin lymphoma.